Proteus CMO talks regulation hurdles, future plans for digital pill

It ’s still the early days, but the FDA’s approval of Proteus Digital Health and Otsuka Pharmaceuticals’ Abilify MyCite has changed the discussion of digital technology in healthcare.
Source: mobihealthnews - Category: Information Technology Source Type: news